Goldman Sachs Group Inc. is helping Reckitt on evaluating options for its formula brand Mead Johnson, including a potential sale, according to the people
Some investors criticised the company's "vague" outlook for this year, as Reckitt shares slumped to their lowest point since March 2020, early in the COVID-19 pandemic
"The chairman and the nomination committee have begun the process to identify the best long-term candidate to take Reckitt on the next phase of its growth and transformation journey," the company said
The CEO told Reuters that the Mead Johnson acquisition had already benefited Reckitt, although it has only just reversed several quarters of decline in that business